The New England Journal of Medicine: Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
In patients with acute stroke and a large infarct of unrestricted size, use of thrombectomy and medical care within 7 hours after symptom onset led to better functional outcomes and lower mortality ...
NEW ORLEANS -- IV tenecteplase (TNKase) could be beneficial as far out as 24 hours after stroke onset in people not getting mechanical thrombectomy, the OPTION trial showed. In people with acute ...
NEW ORLEANS, LA—Administering intra-arterial alteplase after successful endovascular thrombectomy in patients with acute ischemic stroke improves functional outcomes and reduces persistent ...
The American Journal of Managed Care: Intraarterial Alteplase After Thrombectomy May Improve Stroke Recovery: CHOICE2
Intravenous alteplase is beneficial for patients who present with an acute ischemic stroke and salvageable brain tissue on imaging—with or without a large-vessel occlusion (LVO)—up to 24 hours after ...
The effects and risks of the use of intravenous thrombolysis between 4.5 and 24 hours after the onset of a posterior circulation ischemic stroke are not well studied. In a trial conducted in China, we ...
Treatment with the clot-busting drug tenecteplase given between 4.5 and 24 hours after stroke onset improved functional outcomes compared with standard therapy, according to a new study. The ...
Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...